Article

Molecular Mechanism of Enhanced Anticancer Effect of Nanoparticle Formulated LY2835219 via…

Journal of Nanomaterials · 2016 · Xu Tang, author Bin Zeng, author Jian-Kun Gao, author Han-Qiang Liu, author Mingqiang Li, Academic Editor

Key facts

Title Molecular Mechanism of Enhanced Anticancer Effect of Nanoparticle Formulated LY2835219 via p16-CDK4/6-pRb Pathway in Colorectal Carcinoma Cell Line
First author Xu Tang, author Bin Zeng, author Jian-Kun Gao, author Han-Qiang Liu, author Mingqiang Li, Academic Editor
Journal Journal of Nanomaterials
Published May 5, 2016
DOI 10.1155/2016/2095878
Devices mentioned BK110039, K103302
Product codes mentioned KIP, KIT, NDS, NJT, OOI, PCA

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature